Testing a Provider-Level Feedback Intervention to Optimize Postoperative Prescribing

Not Applicable

Completed

• Conditions: Opioid Prescribing
• Interventions: Behavioral: Push reports

• Registration Number: NCT04776928
• Lead Sponsor: University of Michigan

Brief Summary

The objective of this project is to leverage the Michigan Surgical Quality Collaborative's (MSQC) existing network and surgeon performance feedback platform to improve opioid prescribing practices for surgeons within the network found to be prescribing in a manner discordant with published guidelines and to inform best practices for future surgical quality improvement initiatives.

The study is being completed to learn more about the effectiveness, feasibility, and acceptability and that the goal is both to evaluate how effective this intervention and mechanism are for changing surgeon opioid prescribing behavior and to inform best practices for future quality initiatives. The study hypothesizes that provider-level feedback will allow clinicians to tailor postoperative prescribing more closely to patient consumption, and reduce excess postoperative prescribing.

The cohort of surgeons which have been identified as outliers by the Michigan Surgical Quality Collaborative (MSQC) will be be invited to participate in this trial. The study team will send surgeons belonging to sites that signed the Exhibit B-1 form the provider-level push notifications (98 participants). In this study de-identified prescribing data will also be analyzed for sites that do not sign the Exhibit B-1 form (105 participants).

The study team will approach 98 surgeons receiving the provider-level push notifications in one wave.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2021-02-25
• Study First Submitted QC: 2021-02-25
• Study First Posted: 2021-03-02
• Study Start: 2022-03-17
• Primary Completion: 2022-08-17
• Study Completion: 2022-08-17
• Results First Submitted: 2023-08-21
• Status Verified: 2023-11
• Results First Submitted QC: 2023-11-16
• Last Update Submitted: 2023-11-16
• Results First Posted: 2023-11-21
• Last Update Posted: 2023-11-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 217

Inclusion Criteria

• Surgeons already participating in and sharing data with the Michigan Surgical Quality Collaborative (MSQC) who perform procedures of interest
• Surgeons within MSQC who have median prescribing > 1 pill equivalents over the published recommendation
• Surgeons within MSQC who perform surgeries at a hospital that have agreed to participate in this research

Read More

Exclusion Criteria

• Surgeons not identified in the MSQC data as having a valid National Provider Identifier (NPI)

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Provider-level push report notifications	Push reports	Push reports will be sent via using a secure email client. The email will be sent to the email address provided to the study team by the surgeon or site.

Primary Outcome Measures

Name	Time	Method
Change in Opioid Prescribed Following the Intervention	up to 5 months from enrollment	Oral morphine equivalents prescribed adjusted for surgery type as reported through MSQC data.

Trial Locations

Locations (1)

University of Michigan; 🇺🇸 Ann Arbor, Michigan, United States